Discovery of Small-Molecule Inhibitors of HCV NS3-4A Protease as Potential Therapeutic Agents against HCV Infection

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|12|20|2317-2342

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.12, Iss.20, 2005-09, pp. : 2317-2342

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The therapeutic potential of NS3 protease inhibitors in HCV infection

By Goudreau Nathalie   Llinàs-Brunet Montse  

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 9, 2005-09 ,pp. : 1129-1144

Informa Healthcare

Access to resources Recommend Favorite

The Development of Novel HCV NS3-4A Protease Inhibitors

By Hui Chang-Ye   Xie Xiao-Bing   Cao Hong   Huang Sheng-He  

Anti-Infective Agents, Vol. 11, Iss. 2, 2013-07 ,pp. : 125-135

Bentham Science Publishers

Access to resources Recommend Favorite

The Development of Novel HCV NS3-4A Protease Inhibitors

By  

Anti-Infective Agents, Vol. 11, Iss. 2, 2013-07 ,pp. : 125-135

Bentham Science Publishers

Access to resources Recommend Favorite

Macrocyclic Inhibitors of HCV NS3-4A Protease: Design and Structure Activity Relationship

By  

Current Topics in Medicinal Chemistry, Vol. 7, Iss. 13, 2007-07 ,pp. : 1290-1301

Bentham Science Publishers

Access to resources Recommend Favorite

QSAR and Docking Studies of HCV NS3 Serine Protease Inhibitors

By  

Medicinal Chemistry, Vol. 9, Iss. 6, 2013-09 ,pp. : 774-805

Bentham Science Publishers

Access to resources Recommend Favorite